Protein kinase C inhibits CD95 (Fas/APO-1)-mediated apoptosis by at least two different mechanisms in Jurkat T cells

Journal of Immunology

Volumn 163, Issue 9, 1999, Pages 4737-4746

  Ruiz Ruiz, Carmen ^a   Robledo, Gema ^a   Font, Jovita ^b   Izquierdo, Manuel ^c   López Rivas, Abelardo ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CELL SURFACE; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; ENZYME ACTIVATION; ENZYME INHIBITORS; FAS LIGAND PROTEIN; FLAVONOIDS; HUMANS; JURKAT CELLS; LIGANDS; MAP KINASE KINASE 1; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RATS; RECEPTOR AGGREGATION; T-LYMPHOCYTES; ULTRAVIOLET RAYS;

EID: 0032728434     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. Ellis, R. E., J. Yuan, and H. R. Horvitz. 1991. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7:663.
2. Carson, D. A., and J. M. Ribeiro. 1993. Apoptosis and disease. Lancet 341:1251.
3. Nossal, G. J. V. 1994. Negative selection of lymphocytes. Cell 76:229.
4. Cohen, J. J., and R. C. Duke. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10:267.
5. Russell, J. H. 1983. Internal disintegration model of cytotoxic lymphocyte-induced target damage. Immunol. Rev. 72:97.
6. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
7. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B. C. Trauth, et al. 1992. Purification and molecular cloning of the APO-1 antigen, a new member of the TNF/NGF receptor superfamily: sequence identity with the Fas antigen. J. Biol. Chem. 267:10709.
8. Trauth, B. C., C. Klas, A. M. J. Peters, S. Matzku, P. Möller, W. Falk, K. M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
9. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753.
10. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
11. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, et al. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
12. Dhein, J., H. Walczak, C. Bäumier, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
13. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, E.-K. Maan, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
14. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:1129.
15. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
16. Russell, J. H., B. Rush, C. Weaver, and R. Wang. 1993. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90:4409.
17. Dhein, J., P. T. Daniel, B. C. Trauth, A. Oehm, P. Möller, and P. H. Krammer. 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149:3166.
18. Kischkel, F C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, and M. E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/ CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14:5579.
19. Chinnaiyan, A. M., K. O'Rourke, M. Tewari, and V. M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505.
20. Chinnaiyan, A. M., K. Orth, K. O'Rourke, H. Duan, G. G. Poirier, and V. M. Dixit. 1996. Molecular ordering of the cell death pathway. J. Biol. Chem. 271:4573.
21. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/ APO-1) death-inducing signaling complex. Cell 85:817.
22. Boldin, M. P., T. M. Goncharov, Y. V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85:803.
23. Rodriguez-Tarduchy, G., and A. Lopez-Rivas. 1989. Phorbol esters inhibit apoptosis in IL-2 dependent T lymphocytes. Biochem. Biophys. Res. Commun. 164: 1069.
24. Forbes, I. J., P. D. Zalewski, C. Giannakis, and P. A. Cowled. 1992. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester. Exp. Cell Res. 198:367.
25. Illera, V. A., C. E. Perandones, L. L. Stunz, D. A. Mower, Jr., and R. F. Ashman. 1993. Apoptosis in splenic B lymphocytes: regulation by protein kinase C and IL-4. J. Immunol. 151:2965.
26. Eischen, C. M., C. J. Dick, and P. J. Leibson. 1994. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153:1947.
27. Tian, Q., J. L. Taupin, S. Elledge, M. Robertson, and P. Anderson. 1995. Fasactivated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp. Med. 182:865.
28. Sato, T., S. Irie, S. Kitada, and J. C. Reed. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411.
29. Copeland, K. F., A. G. Haaksma, J. Goudsmit, P. H. Krammer, and J. L. Heeney. 1994. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res. Hum. Retroviruses 10:1259.
30. Su, X., T. Zhou, Z. Wang, P. Yang, R. S. Jope, and J. D. Mountz. 1995. Defective expression of hematopoietic cell protein tyrosine phosphatase (HPC) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2:353.
31. Clément, M. V., and I. Stamenkovic. 1996. Superoxide anion is a natural inhibitor of Fas-mediated cell death. EMBO J. 15:216.
32. von Reyher, U., J. Strater, W. Kittstein, M. Gschwendt, P. H. Krammer, and P. Möller. 1998. Colon carcinoma cells use different mechanism to escape CD95-mediated apoptosis. Cancer Res. 18:526.
33. Ruiz-Ruiz, M. C., M. Izquierdo, G. de Murcia, and A. López-Rivas. 1997. Activation of protein kinase C attenuates early signals in Fas-mediated apoptosis. Eur. J. Immunol. 27:1442.
34. Whitehurst, C. E., T. G. Boulton, M. H. Cobb, and T. G. Geppert. 1992. Extracellular signal-regulated kinases in T cells: anti-CD3 and 4-β-phorbol-12-myristate-13-acetate-induced phosphorylation and activation. J. Immunol. 148:3230.
35. Xia, Z., M. Dickens, J. Raingeaud. R. J. Davis, and M. E. Greenbeg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326.
36. Holmström, T. H., S. C. Chow, I. Elo, E. T. Coffey, S. Orrenius, L. Sistonen, and J. E. Eriksson. 1998. Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. J. Immunol. 160:2626.
37. Yeh, J.-H., S.-C. Hsu, S.-H. Han, and M.-Z. Lai. 1998. Mitogen-activated protein kinase kinase antagonized Fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J. Exp. Med. 188:1795.
38. Devary, Y., R. A. Gottlieb, T. Smeal, and M. Karin. 1992. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 71: 1081.
39. Devary, T., C. Rosette, J. A. DiDonato, and M. Karin. 1993. NF-κB activation by ultraviolet light not dependent on a nuclear signal. Science 261:1442.
40. Fornace, A. J. J. 1992. Mammalian genes induced by radiation: activation of genes associated with growth control. Annu. Rev. Genet. 26:507.
41. Martin, S. J., and T. G. Cotter. 1991. Ultraviolet B irradiation of human leukemia HL-60 cells in vitro induces apoptosis. Int. J. Radiat. Biol. 59:1001.
42. Verheij, M., R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, J. M. Kyriakis, et al. 1996. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75.
43. Hen, I., D. Wilhelm, T. Bohler, P. Angel, and K. M. Debatin. 1997. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16:6200.
44. Faris, M., N. Kokot, K. Latinis, S. Kasibhatla, D. R. Green, G. A. Koretzky, and A. Nel. 1998. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J. Immunol. 160:134.
45. Rehemtulla, A., C. A. Hamilton, A. M. Chinnaiyan, and V. M. Dixit. 1997. Ultraviolet radiation-induced apoptosis is mediated by activation of CD95 (Fas/ APO-1). J. Biol. Chem. 272:25783.
46. Aragane, Y., D. Kulms, D. Metze, G. Wilkes, B. Pöppelmann, T. A. Luger, and T. Schwarz. 1997. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J. Cell Biol. 140:171.
47. Gong, J., F. Traganos, and Z. Darzinkiewicz. 1994. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218:314.
48. ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes. J. Exp. Med. 178:1199.
49. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. L. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.
50. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489.
51. Los, M., M. Van de Craen, L. C. Penning, H. Schenk, M. Westendorp, P. A. Baeuerle, W. Dröge, P. H. Krammer, W. Fiers, and K. Schulze-Osthoff. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375:81.
52. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78.
53. Tewari, M., L. T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D. R. Beidler, G. G. Poirier, G. S. Salvesen, and V. M. Dixit. 1995. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose)polymerase. Cell 81:801.
54. Kamitani, T., H. P. Nguyen, and E. T. H. Yeh. 1997. Activation-induced aggregation and processing of the human Fas antigen. J. Biol. Chem. 272:22307.
55. Izquierdo, M., M. C. Ruiz-Ruiz, and A. Lopez-Rivas. 1996. Stimulation of phosphatidylinositol turnover is a key event for Fas-dependent, activation-induced apoptosis in human T lymphocytes. J. Immunol. 157:21.
56. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
57. Peter, M. E., F. C. Kischkel, C. G. Scheuerpflug, J. P. Medema, K. M. Debatin, and P. H. Krammer. 1997. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/ caspase 8) to the CD95 death-inducing signaling complex. Eur. J. Immunol. 27:1207.
58. Klas, C., K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
59. Ni, R., Y. Tomita, K. Matsuda, A. Ichihara, K. Ishimura, J. Ogasawara, and S. Nagata. 1994. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res. 215:332.
60. Drew, L., R. Kumar, D. Bandyopadhyay, and S. Gupta. 1998. Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat T cells. Int. Immunol. 10:877.
61. ras oncoproteins. EMBO J. 11:569.
62. Marais, R., Y. Light, C. Mason, H. Paterson, M. F. Olson, and C. J. Marshall. 1998. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280:109.
63. Latinis, K. M., and G. A. Koretzky. 1996. Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87: 871.
64. Wilson, D. J., K. A. Fortner, D. H. Lynch, R. R. Mattingly, I. G. Macara, J. A. Posada, and R. C. Budd. 1996. JNK, but not MAPK, activation is associated with Fas-mediated apoptosis in human T cells. Eur. J. Immunol. 26:989.
65. Wang, H. G., U. R. Rapp, and J. C. Reed. 1996. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629.
66. Rudert, F., Y. Wang, E. Lindridge, and J. Watson. 1997. Apoptosis through CD95 (Fas/APO-1), but not a CD40/CD95 chimeric receptor, is inhibited by phorbol12-myristate-13-acetate. DNA Cell Biol. 16:197.
67. Bazzoni, F., E. Alejos, and B. Beutler. 1995. Chimeric tumor necrosis factor receptors with constitutive signaling activity. Proc. Natl. Acad. Sci. USA 92: 5376.
68. Häusler, P., G. Papoff, A. Eramo, K. Reif, D. A. Cantrell, and G. Ruberti. 1998. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3 kinase and protein kinase B. Eur. J. Immunol. 28:57.
69. Kodaki, T., R. Woscholski, B. Hallberg, P. Rodriguez-Viciana, J. Doxnward, and P. J. Parker. 1994. The activation of phosphatidylinositol 3-kinase by Ras. Curr. Biol. 4:798.
70. Lu, X., and D. P. Lane. 1993. Differential induction of trariscriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75:765.
71. Caricchio, R., E. A. Reap, and P. L. Cohen. 1998. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis. J. Immunol. 161: 241.
72. Sachsenmaier, C., A. Radler-Pohl, R. Zinck, A. Nordheim, P. Herrlich, and H. J. Rahmsdorf. 1994. Involvement of growth factor receptors in the mammalian UVC response. Cell 78:963.
73. Rosette, C., and M. Karin. 1996. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 274:1194.
74. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K.-M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signalling pathways. EMBO J. 17:1675.
75. Hueber, A. O., M. Zornig, D. Lyon, T. Suda, S. Nagata, and G. I. Evan. 1997. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278:1305.
76. Barr, L. F., S. E. Campbell, and S. B. Baylin. 1997. Protein kinase C-β2 inhibits cycling and decreases c-myc-induced apoptosis in small cell lung cancer cells. Cell Growth Differ. 8:381.
77. Kennedy, N. J., and R. C. Budd. 1998. Phosphorylation of FADD/MORT1 and Fas by kinases that associate with the membrane-proximal cytoplasmic domain of Fas. J. Immunol. 160:4881.
78. Lee, J. H., H. Ryu, M. K. Han, U. H. Kim, and H. T. Chung. 1997. Nitric oxide inhibits capping in HL-60 cells. Biochem. Biophys. Res. Commun. 232:827.
79. Mannick, J. B., X. Q. Miao, and J. S. Stamler. 1997. Nitric oxide inhibits Fas-induced apoptosis. J. Biol. Chem. 272:24125.
80. Hartwig, J. H., M. Thelen, A. Rosen, P. A. Janmey, A. C. Nairn, and A. Aderem. 1992. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature 356:618.
81. Aderem, A. 1992. Signal transduction and the actin cytoskeleton: the roles of MARCKS and profilin. Trends Biochem. Sci. 17:438.
82. Blackshear, P. J. 1993. The MARCKS family of cellular protein kinase C substrates. J. Biol. Chem. 268:1501.
83. Zhang, F., B. Yang, J. A. Odin, Z. Shen, C. T. Lin, J. C. Unkeless, and K. Jacobson. 1995. Lateral mobility of FcγRIIa is reduced by protein kinase C activation. FEBS Lett. 376:77.
84. Sato, A., F. Tanabe, M. Ito, E. Ishida, and S. Shigela. 1990. Protein kinase C inhibitors enhance concanavalin A cap formation in polymorphonuclear leukocytes. Int. J. Immunopharmacol. 12:121.